DMSO is worth evaluating as an alternative to DMF when the process needs a polar aprotic solvent for dissolution or a compatible reaction. The reason to consider the change is clear: DMF carries reproductive toxicity and liver toxicity concerns, together with specific EU requirements for controlling worker exposure.
DMSO offers a more favourable toxicological starting point, but a successful change also needs to preserve reaction performance and product quality. Its higher boiling point and different chemical behaviour make this a process development decision rather than a simple purchasing substitution.
In this article
Why DMF attracts greater health concern
DMF is absorbed through the skin as well as by inhalation, and liver injury is an important occupational concern. In the EU it has a harmonised reproductive toxicity classification of Category 1B, with hazard statement H360D concerning harm to the unborn child. See the WHO assessment of DMF and ECHA’s identification document.
This means that an assessment based only on vapour extraction is incomplete. Charging, sampling, cleaning and maintenance can involve liquid contact, so the exposure assessment has to address both routes.
DMSO has evidence of relatively low acute systemic toxicity, including in published animal toxicology work. That is a useful advantage for solvent screening, not a statement that all exposure levels, formulations or uses are harmless.
What the EU DMF restriction requires
REACH Annex XVII entry 76 addresses DMF at concentrations of 0.3% or above. Its required worker DNELs are 6 mg/m³ by inhalation and 1.1 mg/kg body weight/day by skin exposure. Relevant chemical safety reports and safety data sheets must include them, and manufacturing and use require controls that keep exposure below them. The general date was 12 December 2023; the specified polyurethane coating and membrane uses followed in 2024, and synthetic fibre spinning in 2025. All these dates have passed as of October 2026. See Regulation (EU) 2021/2030.
These worker exposure values are not product impurity limits. DMF remains usable where applicable requirements are met; describing it simply as banned in Europe would be misleading.
Where a validated DMSO process eliminates DMF, it can also eliminate the need to manage DMF under that particular entry in the changed operation. Any remaining DMF-containing streams still need their own assessment. General chemical registration, classification, safety documentation and workplace obligations continue to apply to the replacement process.
The pharmaceutical residual solvent distinction
ICH Q3C(R9) lists DMSO as Class 3 and DMF as Class 2. DMF has a PDE of 8.8 mg/day and an Option 1 limit of 880 ppm. For Class 3, the guideline accepts up to 50 mg/day without additional toxicological justification, corresponding to 5,000 ppm under Option 1’s 10 g/day product assumption. These are pharmaceutical residual-solvent provisions, not raw-material specifications or EU workplace limits.
The distinction gives pharmaceutical process teams a concrete reason to evaluate DMSO. Actual residual solvent acceptance must still fit the product, dosage, quality requirements and applicable regulatory filing. It does not follow that every product may simply retain 5,000 ppm DMSO.
Process differences that determine whether DMSO fits
| Property | DMSO | DMF | Consequence for a replacement study |
|---|---|---|---|
| CAS number | 67-68-5 | 68-12-2 | Confirm substance identity in specifications and safety documents |
| Normal boiling point | About 189°C | About 153°C | DMSO may require a different removal or recovery strategy |
| Melting point | About 18.5°C | About −61°C | DMSO may solidify in cool storage or transfer conditions |
| Water miscibility | Miscible | Miscible | Neither provides a separate organic phase simply by adding water |
| Vapour pressure | 59.4 Pa at 20°C | 490 Pa at 25°C | Reference temperatures differ; these values are not a precise same-temperature exposure ratio |
Reference data: ILO/WHO DMSO safety card and ILO/WHO DMF safety card. These are reference properties of the substances, not YUJI sales specifications. Neither boiling point is a recommended processing temperature.
Begin by confirming DMF’s role in the existing route. If it mainly dissolves the reactants, DMSO may be a reasonable screening candidate. If DMF helps generate a reactive intermediate, the change is more fundamental. In Vilsmeier chemistry, for example, DMF is part of the reagent system; DMSO does not reproduce that function by replacing the same liquid volume. A checked Organic Syntheses procedure illustrates DMF’s role in forming the Vilsmeier reagent.
For a solvent-only change, test the actual concentration and water content, then follow conversion, selectivity, impurity profile and heat release. Also check whether the product remains dissolved during cooling and whether it crystallises or separates as intended. The result can differ even when both solvents dissolve the starting material.
Plan isolation at the same time. Compare washing, extraction, solvent exchange or vacuum removal against product stability and residual solvent targets. DMSO’s low volatility may reduce evaporative loss, but it can also make final removal harder. Recovery cost and energy demand need process data rather than an assumption based on solvent price.
Keep the safety advantage during scale-up
DMSO’s lower toxicological concern does not make a DMF recipe automatically transferable. Review reagent compatibility and reaction calorimetry before scale-up, particularly for strong bases, oxidants or activation reagents. A solvent that is acceptable in one reaction may react or decompose in another.
Skin protection remains necessary. DMSO can promote absorption of other materials, so assess the whole mixture and select gloves using permeation data for the operating conditions. Low room-temperature volatility also does not remove exposure from heated operations, aerosols or spills.
The most persuasive case for DMSO is therefore specific: it provides the solvent function needed by the process, reduces reliance on DMF with its toxicological and EU exposure concerns, and gives acceptable product quality after isolation. Those results establish a practical replacement case without relying on a broad claim that one solvent is always safer in every operation.
If you are evaluating a DMF-to-DMSO change, YUJI can discuss the DMSO specification, water requirement and product documents needed for your trial and sourcing review.